<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=7phcy%3AV8.00_GTS.Probleemstelling</id>
	<title>7phcy:V8.00 GTS.Probleemstelling - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=7phcy%3AV8.00_GTS.Probleemstelling"/>
	<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;action=history"/>
	<updated>2026-04-06T05:09:19Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;diff=34601&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Tekst vervangen - &quot;{{DISPLAYTITLE:.*}}&quot; door &quot;&quot;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;diff=34601&amp;oldid=prev"/>
		<updated>2020-08-26T12:31:05Z</updated>

		<summary type="html">&lt;p&gt;Tekst vervangen - &amp;quot;{{DISPLAYTITLE:.*}}&amp;quot; door &amp;quot;&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 26 aug 2020 12:31&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{DISPLAYTITLE:Probleemstelling|Probleemstelling}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;diff=30791&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Tekst vervangen - &quot;{{#customtitle:&quot; door &quot;{{DISPLAYTITLE:&quot;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;diff=30791&amp;oldid=prev"/>
		<updated>2020-07-20T01:34:33Z</updated>

		<summary type="html">&lt;p&gt;Tekst vervangen - &amp;quot;{{#customtitle:&amp;quot; door &amp;quot;{{DISPLAYTITLE:&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 20 jul 2020 01:34&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;#customtitle&lt;/del&gt;:Probleemstelling|Probleemstelling}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;DISPLAYTITLE&lt;/ins&gt;:Probleemstelling|Probleemstelling}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;diff=6293&amp;oldid=prev</id>
		<title>Kheitmann: Copy of V6.12</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_GTS.Probleemstelling&amp;diff=6293&amp;oldid=prev"/>
		<updated>2014-01-13T11:19:10Z</updated>

		<summary type="html">&lt;p&gt;Copy of V6.12&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nieuwe pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{#customtitle:Probleemstelling|Probleemstelling}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
===Probleemstelling===&lt;br /&gt;
&lt;br /&gt;
Tijdens de implementatie van de berichten voor medicatiegegevens is gebleken dat de ‘veelvormige’ structuur van het datatype GTS veel leveranciers voor problemen stelt. Het genereren van GTS syntax is goed te automatiseren, maar het verwerken (parsen) ervan kan erg complex zijn. De reden hiervoor is dat een verzender zelf kan bepalen welke uitdrukkingsvorm gebruikt wordt om een bepaald tijdschema aan te duiden, terwijl een ontvanger voorbereid moet zijn op alle mogelijke variaties die gehanteerd kunnen worden.&lt;br /&gt;
&lt;br /&gt;
Dit is inherent aan het feit dat GTS een ‘algoritme’ is dat meerdere vormen (syntax) met dezelfde betekenis (semantiek) mogelijk maakt. Er kunnen daarom de volgende gevaren zijn als GTS vrijuit wordt toegepast bij de implementatie van medicatiedoseerschema’s:&lt;br /&gt;
* Leveranciers maken fouten bij het verwerken van doseerschema’s in hun systeem.&lt;br /&gt;
&amp;amp;ensp;&amp;amp;ensp;&amp;amp;ensp;&amp;amp;ensp;&amp;amp;rArr;Merk op dat dit potentieel tot fouten bij voorschrijven of bewaking kan leiden!&lt;br /&gt;
* Leveranciers kunnen sommige aangeleverde doseerschema’s simpelweg niet aan.&lt;br /&gt;
&amp;amp;ensp;&amp;amp;ensp;&amp;amp;ensp;&amp;amp;ensp;&amp;amp;rArr; Hierdoor onstaat onvolledige informatievoorziening naar vragende zorgverleners!&lt;br /&gt;
* Het is verleidelijk om vrije tekst te gebruiken in plaats van gestructureerde informatie.&lt;br /&gt;
&amp;amp;ensp;&amp;amp;ensp;&amp;amp;ensp;&amp;amp;ensp;&amp;amp;rArr; Gevolg is dat er geen basis meer is voor geautomatiseerde medicatiebewaking!&lt;/div&gt;</summary>
		<author><name>Kheitmann</name></author>
	</entry>
</feed>